207989-88-6

Basic information

• Product Name: Methanesulfonic acid, trifluoro-, 4-(5-oxo-2-pyrrolidinyl)phenyl ester
• CAS NO: 207989-88-6
• Molecular Formula: C11H10F3NO4S
• Molecular Weight: 309.266
• Mol File: 207989-88-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Methanesulfonic acid, trifluoro-, 4-(5-oxo-2-pyrrolidinyl)phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Methanesulfonic acid, trifluoro-, 4-(5-oxo-2-pyrrolidinyl)phenyl ester(207989-88-6)
• EPA Substance Registry System: Methanesulfonic acid, trifluoro-, 4-(5-oxo-2-pyrrolidinyl)phenyl ester(207989-88-6)

Safety Data

• Hazardous Substances Data: 207989-88-6(Hazardous Substances Data)

Upstream product

• 207989-87-5 5-(4-hydroxy-phenyl)-pyrrolidin-2-one 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 100-66-3 methoxybenzene 
• 128100-35-6 5-(4-methoxyphenyl)pyrrolidin-2-one 
• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 

Downstream Products

• 405201-72-1 4-[1-[(tert-butoxycarbonyl)amino]-4-(2,6-difluorophenyl)-4-oxobutyl]phenyl trifluoromethanesulphonate 
• 405201-93-6 5-(2,6-difluorophenyl)-2-[4-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3,4-dihydro-2H-pyrrol 
• 1147392-48-0 5-(4'-(2-((R)-2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)pyrrolidin-2-one 
• 405201-76-5 tert-butyl 2-oxo-5-(4-{[(trifluoromethyl)sulphonyl]oxy}phenyl)-1-pyrrolidinecarboxylate 
• 461440-95-9 N-tert-butyloxycarbonyl-5-(4-cyanophenyl)-2-pyrrolidinone 
• 339087-31-9 4-(5-oxopyrrolidin-2-yl)benzonitrile 

Relevant articles and documents

BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Biphenyl derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the H3 histamine receptor. (Ia) Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders, such as cognitive disorders, epilepsy, brain trauma, depression, obesity, disorders of sleep and wakefulness, such as narcolepsy, shift-work syndrome, drowsiness as a side effect from a medication, maintenance of vigilance to aid in completion of tasks and the like, cataplexy, hypersomnia, somnolence syndrome, jet lag, sleep apnea and the like, attention deficit hyperactivity disorder (ADHD), schizophrenia, allergies, allergic responses in the upper airway, allergic rhinitis, nasal congestion, dementia, Alzheimer's disease, pain and the like.

2-(ARYL)AZACYCLYLMETHYL CARBOXYLATES, SULFONATES, PHOSPHONATES, PHOSPHINATES AND HETEROCYCLES AS S1P RECEPTOR AGONISTS

The present invention encompasses compounds of Formula I: as well as the pharmaceutically acceptable salts thereof. The compounds are S1P1/Edg1 receptor agonists and thus have immunosuppressive, anti-inflammatory and hemostatic activities by mo

2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives

The invention relates to novel 2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives of the formula (I) in whichAr represents substituted phenyl,to a plurality of processes for their preparation and to their use as pesticides.